Jazmine Nesvik, DO
Dermatology · Alexandria, MNNPI 1457904732
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 28.3% of the total. Reporting peaked in 2022 at $4,847 and has fallen 99.4% since, to $28 in 2025. Among dermatology clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 177 payments — averaging $52.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$3K
- Sanofi$2K
- Amgen$2K
- AbbVie$604
- Sun Pharmaceutical Industries Inc.$462
- Lilly USA, LLC$340
- plus $2K from 18 others
What the payments were for
- Consulting fees$4,91653%
- Food & beverage$4,16445%
- Education$1602%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 14 | $2,617 |
| Sanofi | 15 | $2,006 |
| Amgen | 5 | $1,580 |
| AbbVie | 42 | $604 |
| Sun Pharmaceutical Industries Inc. | 15 | $462 |
| Lilly USA, LLC | 20 | $340 |
| UCB, Inc. | 9 | $221 |
| Dermavant Sciences, Inc. | 4 | $198 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $177 |
| Johnson & Johnson | 10 | $161 |
| E.r. Squibb & Sons, L.L.C. | 6 | $139 |
| Arcutis Biotherapeutics, Inc. | 6 | $103 |
| Journey Medical Corporation | 1 | $98 |
| Pfizer | 6 | $92 |
| Boehringer Ingelheim | 3 | $82 |
| Novartis | 3 | $65 |
| LEO Pharma Inc. | 3 | $57 |
| Biofrontera Inc. | 3 | $56 |
| Dermira, Inc. | 2 | $49 |
| Stemline Therapeutics Inc. | 2 | $43 |
| Incyte Corporation | 2 | $35 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $28 |
| Galderma Laboratories, L.p. | 1 | $13 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,239 in reported general payments places this provider in the 90th percentile of 273 dermatology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 13 | $102,554 |
| Dupixent PenDupilumab | 21 | $78,613 |
| Ketoconazole | 130 | $3,077 |
| Metronidazole | 43 | $2,783 |
| Clobetasol Propionate | 68 | $2,701 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 34 | $1,758 |
| Ciclopirox | 13 | $503 |
| Triamcinolone Acetonide | 36 | $373 |
| Doxycycline Hyclate | 19 | $371 |
| Fluocinonide | 11 | $298 |
| Hydrocortisone | 20 | $128 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Alexandria
- Kristina ShafferEagan$538K
- Margareth Pierre-LouisMinneapolis$439K
- Maria HordinskyMinneapolis$85K
- Afsaneh AlaviRochester$71K
- Todd SeelhammerSaint Paul$63K
- Brittney SchultzMinneapolis$52K
- David PearsonMinneapolis$46K
- Phillip EckerWayzata$31K
- Noah GoldfarbMinneapolis$30K
- Saranya WylesRochester$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.